View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
mFOLFOX-6 - Nivolumab 240 / Trastuzumab 4 / Oxaliplatin 85 / Folinic Acid 400 / Fluorouracil 2400, Cancer Esophagus, Esophagogastric junction and Stomach, Cycle 2+
Protocol-ID: 2422 V1.0 (Mini), mFOLFOX-6 (OXAL85/CFOL400/FU2400)/NIVO240/TRAS4, Esophagus Ca/AEG/Gastric Ca, C2+Indication(s)
- Gastric Cancer (HER2+); ICD-10 C16.-, C16.0
- Esophageal Cancer (Adenocarcinoma of the esophagogastric junction (AEG), HER2+); ICD-10 C15.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 01.09.2023